Familial progressive hyper- and hypopigmentation and malignancy in two families with new mutations in KITLG
1Department of Dermatology, Birmingham Children's Hospital, NHS Foundation Trust, Birmingham, UK.
Background:
Familial progressive hyper- and hypopigmentation (FPHH) is an autosomal dominant skin condition presenting in childhood with generalized macular dyspigmentation, usually reported in patients of East Asian origin. It overlaps phenotypically with other dyschromatoses, but can now be distinguished by mutations in the KIT ligand gene (KITLG).
Aim:
We report two unrelated white families with similar phenotypic presentations of FPHH developing in early childhood in several generations.
Methods:
Sanger sequencing of the exons and flanking introns of KITLG was performed.
Results:
This identified a new heterozygous missense mutation in each family (p.Thr34Asn and p.Val37Gly, respectively). Of the six affected individuals examined by us, two had cancer: a 62-year-old man in family 1 had developed two primary melanomas and a pharyngeal carcinoma, and a 42-year-old woman in family 2 had developed thyroid carcinoma. All had unusually sparse lateral eyebrows, a finding not previously reported in this condition.
Conclusions:
We summarize the genetic spectrum of the dyschromatoses and discuss a possible increased risk of malignancy in FPHH.
More Related Videos
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
Pleiotropy
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Cytoskeletal Linker Proteins - Plakins


